Literature DB >> 20717154

Genome editing with engineered zinc finger nucleases.

Fyodor D Urnov1, Edward J Rebar, Michael C Holmes, H Steve Zhang, Philip D Gregory.   

Abstract

Reverse genetics in model organisms such as Drosophila melanogaster, Arabidopsis thaliana, zebrafish and rats, efficient genome engineering in human embryonic stem and induced pluripotent stem cells, targeted integration in crop plants, and HIV resistance in immune cells - this broad range of outcomes has resulted from the application of the same core technology: targeted genome cleavage by engineered, sequence-specific zinc finger nucleases followed by gene modification during subsequent repair. Such 'genome editing' is now established in human cells and a number of model organisms, thus opening the door to a range of new experimental and therapeutic possibilities.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20717154     DOI： 10.1038/nrg2842

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN： 1471-0056            Impact factor:   53.242


  91 in total

Review 1.  DNA recognition by Cys2His2 zinc finger proteins.

Authors:  S A Wolfe; L Nekludova; C O Pabo
Journal:  Annu Rev Biophys Biomol Struct       Date:  2000

2.  Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses.

Authors:  Manu Kohli; Carlo Rago; Christoph Lengauer; Kenneth W Kinzler; Bert Vogelstein
Journal:  Nucleic Acids Res       Date:  2004-01-02       Impact factor: 16.971

3.  Structure of Aart, a designed six-finger zinc finger peptide, bound to DNA.

Authors:  David J Segal; Justin W Crotty; Mital S Bhakta; Carlos F Barbas; Nancy C Horton
Journal:  J Mol Biol       Date:  2006-08-11       Impact factor: 5.469

4.  DNA synthesis dependent on genetic recombination: characterization of a reaction catalyzed by purified bacteriophage T4 proteins.

Authors:  T Formosa; B M Alberts
Journal:  Cell       Date:  1986-12-05       Impact factor: 41.582

5.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases.

Authors:  Fyodor D Urnov; Jeffrey C Miller; Ya-Li Lee; Christian M Beausejour; Jeremy M Rock; Sheldon Augustus; Andrew C Jamieson; Matthew H Porteus; Philip D Gregory; Michael C Holmes
Journal:  Nature       Date:  2005-04-03       Impact factor: 49.962

6.  Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies.

Authors:  Laetitia Malphettes; Yevgeniy Freyvert; Jennifer Chang; Pei-Qi Liu; Edmond Chan; Jeffrey C Miller; Zhe Zhou; Thu Nguyen; Christina Tsai; Andrew W Snowden; Trevor N Collingwood; Philip D Gregory; Gregory J Cost
Journal:  Biotechnol Bioeng       Date:  2010-08-01       Impact factor: 4.530

7.  Efficient gene targeting in Drosophila with zinc-finger nucleases.

Authors:  Kelly Beumer; Gargi Bhattacharyya; Marina Bibikova; Jonathan K Trautman; Dana Carroll
Journal:  Genetics       Date:  2006-02-01       Impact factor: 4.562

8.  An affinity-based scoring scheme for predicting DNA-binding activities of modularly assembled zinc-finger proteins.

Authors:  Jeffry D Sander; Peter Zaback; J Keith Joung; Daniel F Voytas; Drena Dobbs
Journal:  Nucleic Acids Res       Date:  2008-12-04       Impact factor: 16.971

9.  Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases.

Authors:  Tomoji Mashimo; Akiko Takizawa; Birger Voigt; Kazuto Yoshimi; Hiroshi Hiai; Takashi Kuramoto; Tadao Serikawa
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

10.  High-frequency modification of plant genes using engineered zinc-finger nucleases.

Authors:  Jeffrey A Townsend; David A Wright; Ronnie J Winfrey; Fengli Fu; Morgan L Maeder; J Keith Joung; Daniel F Voytas
Journal:  Nature       Date:  2009-04-29       Impact factor: 49.962
View more
  759 in total

1.  The iCRISPR platform for rapid genome editing in human pluripotent stem cells.

Authors:  Zengrong Zhu; Federico González; Danwei Huangfu
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

2.  Creating cancer translocations in human cells using Cas9 DSBs and nCas9 paired nicks.

Authors:  Benjamin Renouf; Marion Piganeau; Hind Ghezraoui; Maria Jasin; Erika Brunet
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

3.  Genome editing in human stem cells.

Authors:  Susan M Byrne; Prashant Mali; George M Church
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

4.  In planta gene targeting.

Authors:  Friedrich Fauser; Nadine Roth; Michael Pacher; Gabriele Ilg; Rocío Sánchez-Fernández; Christian Biesgen; Holger Puchta
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-23       Impact factor: 11.205

5.  Gene editing: not just for translation anymore.

Authors:  Moira A McMahon; Meghdad Rahdar; Matthew Porteus
Journal:  Nat Methods       Date:  2011-12-28       Impact factor: 28.547

6.  Single-Homology-Arm Linear DNA Recombination by the Nonhomologous End Joining Pathway as a Novel and Simple Gene Inactivation Method: a Proof-of-Concept Study in Dietzia sp. Strain DQ12-45-1b.

Authors:  Shelian Lu; Yong Nie; Meng Wang; Hong-Xiu Xu; Dong-Ling Ma; Jie-Liang Liang; Xiao-Lei Wu
Journal:  Appl Environ Microbiol       Date:  2018-09-17       Impact factor: 4.792

Review 7.  CRISPR-Cas systems for editing, regulating and targeting genomes.

Authors:  Jeffry D Sander; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-03-02       Impact factor: 54.908

8.  Structure, transcription and post-transcriptional regulation of the bread wheat orthologs of the barley cleistogamy gene Cly1.

Authors:  Shunzong Ning; Ning Wang; Shun Sakuma; Mohammad Pourkheirandish; Jianzhong Wu; Takashi Matsumoto; Takato Koba; Takao Komatsuda
Journal:  Theor Appl Genet       Date:  2013-02-05       Impact factor: 5.699

9.  TALEN-mediated gene targeting in porcine spermatogonia.

Authors:  Lin Tang; Alla Bondareva; Raquel González; Jose R Rodriguez-Sosa; Daniel F Carlson; Dennis Webster; Scott Fahrenkrug; Ina Dobrinski
Journal:  Mol Reprod Dev       Date:  2018-02-22       Impact factor: 2.609

Review 10.  CRISPR-Cas9: A multifaceted therapeutic strategy for cancer treatment.

Authors:  Itishree Kaushik; Sharavan Ramachandran; Sanjay K Srivastava
Journal:  Semin Cell Dev Biol       Date:  2019-05-04       Impact factor: 7.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.